Spiegel, R. C., Nawroth, P. P., & Kasperk, C. (2014). The effect of zoledronic acid on the fracture risk in men with osteoporosis. Journal of endocrinological investigation, 37(3), . https://doi.org/10.1007/s40618-013-0038-5
Chicago Style (17th ed.) CitationSpiegel, Rainer Christian, Peter Paul Nawroth, and Christian Kasperk. "The Effect of Zoledronic Acid on the Fracture Risk in Men with Osteoporosis." Journal of Endocrinological Investigation 37, no. 3 (2014). https://doi.org/10.1007/s40618-013-0038-5.
MLA (9th ed.) CitationSpiegel, Rainer Christian, et al. "The Effect of Zoledronic Acid on the Fracture Risk in Men with Osteoporosis." Journal of Endocrinological Investigation, vol. 37, no. 3, 2014, https://doi.org/10.1007/s40618-013-0038-5.
Warning: These citations may not always be 100% accurate.